Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV‑2 Strains using SSSCPreds

Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV‑2 Strains using SSSCPreds

Bibliographic Details
Main Authors:	Hiroshi Izumi, Laurence A. Nafie, Rina K. Dukor
Format:	Article
Language:	English
Published:	American Chemical Society 2021-07-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.1c03055

Similar Items

SSSCPreds: Deep Neural Network-Based Software for the Prediction of Conformational Variability and Application to SARS-CoV‑2
by: Hiroshi Izumi, et al.
Published: (2020-11-01)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
by: Chengchao Ding, et al.
Published: (2021-08-01)

Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape
by: Shengyuan Dang, et al.
Published: (2022-05-01)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
by: Ranjeet Singh Mahla, et al.
Published: (2022-02-01)

Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
by: Khadija Khan, et al.
Published: (2023-12-01)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
by: Leander Witte, et al.
Published: (2023-01-01)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
by: Yiska Weisblum, et al.
Published: (2020-10-01)

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies.
by: Marta Alenquer, et al.
Published: (2021-08-01)

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
by: Marta Alenquer, et al.
Published: (2021-08-01)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
by: Taichi Kuramochi, et al.
Published: (2022-12-01)

P09-07. Balancing reversion of CTL and neutralizing antibody escape mutations within HIV-1 Env upon transmission
by: Purcell DF, et al.
Published: (2009-10-01)

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
by: Zhennan Zhao, et al.
Published: (2022-08-01)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
by: Ragonnet-Cronin, M, et al.
Published: (2023)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
by: Manon Ragonnet-Cronin, et al.
Published: (2023-06-01)

SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode
by: Jule Goike, et al.
Published: (2023-12-01)

Evolution and transmission of stable CTL escape mutations in HIV infection.
by: Goulder, P, et al.
Published: (2001)

HIV evolution: CTL escape mutation and reversion after transmission.
by: Leslie, A, et al.
Published: (2004)

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages
by: Franck Touret, et al.
Published: (2023-04-01)

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
by: Fangzhu Zhao, et al.
Published: (2022-09-01)

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
by: Thomas Krey, et al.
Published: (2013-01-01)

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
by: Lin Yang, et al.
Published: (2021-11-01)

Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
by: Mohamed Hendy, et al.
Published: (2021-11-01)

The effect of spike mutations on SARS-CoV-2 neutralization
by: Chloe Rees-Spear, et al.
Published: (2021-03-01)

Persistent BK Polyomavirus Viruria Is Associated with Accumulation of VP1 Mutations and Neutralization Escape
by: Dorian McIlroy, et al.
Published: (2020-07-01)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
by: Ruofan Li, et al.
Published: (2022-08-01)

Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD
by: Antonia Sophia Peter, et al.
Published: (2022-07-01)

Chiroptical Properties and Conformation of Four Lasiocepsin-Related Antimicrobial Peptides: Structural Role of Disulfide Bridges
by: Markéta Pazderková, et al.
Published: (2020-05-01)

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
by: Ayaka Washizaki, et al.
Published: (2022-09-01)

Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
by: Aleksandr V. Kudriavtsev, et al.
Published: (2022-07-01)

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
by: Allison J. Greaney, et al.
Published: (2021-07-01)

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
by: Yusuke Higuchi, et al.
Published: (2021-06-01)

Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies
by: James S. Koopman, et al.
Published: (2021-09-01)

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
by: Dmitri Dormeshkin, et al.
Published: (2022-09-01)

Integrating Conformational Dynamics and Perturbation-Based Network Modeling for Mutational Profiling of Binding and Allostery in the SARS-CoV-2 Spike Variant Complexes with Antibodies: Balancing Local and Global Determinants of Mutational Escape Mechanisms
by: Gennady Verkhivker, et al.
Published: (2022-07-01)

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
by: Denise Haslwanter, et al.
Published: (2021-10-01)

Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variants
by: Neda Jalali, et al.
Published: (2022-09-01)

Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
by: Blanca J. Valdovino-Navarro, et al.
Published: (2022-10-01)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022-11-01)

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.
by: Chia Yin Lee, et al.
Published: (2011-12-01)

Nano-Enabled Antivirals for Overcoming Antibody Escaped Mutations Based SARS-CoV-2 Waves
by: Aminur Rahman, et al.
Published: (2023-08-01)